GI Dynamics touts preliminary Endobarrier data in adolescent prediabetes treatment

This study, in conjunction with many additional investigator-initiated studies around the world, is completing a picture of clinical evidence that further reinforces the broader safety and efficacy profile of EndoBarrier,” prez & CEO Scott Schorer said in a press release. Earlier this month, GI Dynamics won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System for its EndoBarrier system. This status is the highest of 4 levels, which will bring in full reimbursement for the company at the 143 participating hospitals. Payers at these hospitals will be required to cover the gaps in treatment costs for the EndoBarrier procedure, according to GI Dynamics. The post GI Dynamics touts preliminary Endobarrier data in adolescent prediabetes treatment appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Clinical Trials Weight loss GI Dynamics Source Type: news